Diagnosis of Diabetic Neuropathy Using Simple Somatic and a New Autonomic (Neuropad^®) Tests in the Clinical Practice

Abstract

Aim: The global spread of diabetes (DM) and the importance of early therapeutic intervention determine the need of simple, inexpensive and sensitive methods for diagnosis of diabetic complications in the general practice. The aim of this study was to assess a new instrument – the plaster Neuropad in diagnosing the sudomotor diabetic dysfunction and to investigate the correlates of Neuropad data with diabetic complications.

Patients and methods: In this cross-sectional study participated 264 inpatients (M/F=126/138) with DM type 1/2 (61/203), mean age 55.4±12.0 and DM duration of 9.3±7.1 years. According to hospital records were registered: anthropometric data; fasting plasma glucose and HbA1c; presence of micro-(retino-, nephro-, neuropathy), and macrovascular (arterial hypertension, coronary artery disease and/or brain vascular disease) complications, and neuropathic symptoms were evaluated. For investigation of somatic DN a modified Neuropathy Disability Score (NDS) and for sudomotor autonomic DN – Neuropad were used.

Results: Neuropad showed the highest between-feet correlation of 0.91 compared to all other individual tests and the NDS. Neuropad was able to separate patients in groups with different general risk profile, including age, duration of DM, presence of coronary and/or brain vascular disease, nephropathy, and retinopathy. Moreover, Neuropad differentiated patient groups by their stage of DN, evaluated by symptoms, diagnosis, the individual somatic tests and with the highest significance – by NDS. Most sensitive for detecting DN was NDS ≥ 3, followed by Achilles reflexes, vibration perception (128 Hz tuning fork) and Neuropad. A borderline or abnormal result of Neuropad showed sensitivity=76.3/79.3, specificity=56.1/42.9, positive=86.3/62.8 and negative=39.5/63.0 predictive values, and diagnostic accuracy 72.2/62.9%, compared to the indices for presence of somatic DN (NDS ≥ 3)/foot at risk (NDS ≥ 6) respectively.

Conclusions: Screening for DN must cover somatic and autonomic disturbances. Neuropad is a new sensitive and appropriate for everyday clinical use test for detecting sudomotor DN and identification of patients at higher risk for chronic diabetes complications.

diabetic neuropathy - sudomotor dysfunction - NDS - neuropad

References

• 1 Abbott CA, Carrington AL, Ashe H. et al . North-West Diabetes Foot Care Study: The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort.  Diabet Med. 2002;  19 377-384
• 2 American Diabetes Association. . Standards of Medical Care in Diabetes.  Diabetes Care. 2004 Jan;  27 (S 01)
• 3 Bilen H, Atmaca A, Akcay G. Neuropad indicator test for diagnosis of sudomotor dysfunction in type 2 diabetes.  Adv Ther.. 2007 Sep-Oct;  24 ((5)) 1020-1027
• 4 Boulton AJ, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy.  Diabet Med.. 1998 Jun;  15 ((6)) 508-514
• 5 Boulton AJ. Guidelines for diagnosis and outpatient management of diabetic peripheral neuropathy. European Association for the Study of Diabetes, Neurodiab.  Diabetes Metab.. 1998 Nov;  24 (S 03) 55-65
• 6 Boulton AJM, Malik RA, Arezzo JC. et al . Diabetic Somatic Neuropathies.  Diabetes Care. 2004;  27 ((6)) 1458-1486
• 7 Boulton AJM. The diabetic foot: from art to science. The 18^th Camillo Golgi lecture.  Diabetologia. 2004;  47 1343-1353
• 8 Cabezas-Cerrato J. The prevalence of diabetic neuropathy in Spain: a study in primary care and hospital clinic groups.  Diabetologia. 1998;  1 1263-1269
• 9 Dyck PJ, Katz KM, Karnes JL. et al . The prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study.  Neurology. 1993;  43 817-824
• 10 Ewing DJ, Martyn CN, Young RJ. et al . The value of cardiovascular autonomic function tests: 10 years experience in diabetes.  Diabetes Care.. 1985 Sep-Oct;  8 ((5)) 491-498
• 11 Fealey RO. The thermoregulatory sweat test.. In: Low PA , editor. Clinical autonomic disorders: evaluation and management. Boston: Little, Brown and Company; 1993: 217-229
• 12 Grant IA, O’Brien P, Dyck PJ. Ch.8 Neuropathy tests and normative results.. In: Diabetic Neuropathy. 2nd ed. Eds. PJ Dyck and PK Thomas. Publ. WB Saunders Co; 1999: 123-141
• 13 Guttmnn L. The management of the quinizarin sweat test (QST).  Postgrad Med J. 1947;  23 353-366
• 14 Kamenov Z, Christov V, Yankova T. Erectile dysfunction in diabetic men – linked more to microangiopathic complications and neuropathy than to macroangiopathic disturbances.  Journal of Men's Health and Gender;. 2007;  4 ((1)) 64-73
• 15 Kumar S, Fernando DJ, Veves A. et al . Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration.  Diabetes Res Clin Pract. 1991;  13 63-67
• 16 Liatis S, Marinou K, Tentolouris N. et al . Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus.  Diabet Med.. 2007 Dec;  24 ((12)) 1375-1380
• 17 Low PA. Sudomotor function.. Publ. G.Thieme Verlag; 2003: 274-278
• 18 Low VA, Sandroni P, Fealey RD. et al . Detection of small-fiber neuropathy by sudomotor testing.  Muscle Nerve.. 2006 Jul;  34 ((1)) 57-61
• 19 Lang E, Spitzer A, Claus O. et al . Stimulation of sudomotor axon reflex mechanism by carbachol in healthy subjects and patients suffering from diabetic polyneuropathy.  Acta Neurol Scand. 1995;  91 251-254
• 20 Tentolouris N. et al . Sudomotor dysfunction is associated with foot ulceration in diabetes Diabet.  Med.. 2009;  26 302-305
• 21 Papanas N, Papatheodorou K, Papazoglou D. et al . Reproducibility of the new indicator test for sudomotor function (Neuropad) in patients with type 2 diabetes mellitus: short communication.  Exp Clin Endocrinol Diabetes.. 2005 Dec;  113 ((10)) 577-581
• 22 Papanas N. et al . Evaluation of a new Indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients.  Exp Clin Endocrinology Diabetes. 2005;  113 1-4
• 23 Pham H, Armstrong DG, Harvey C. et al . Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.  Diabetes Care. 2000;  23 606-611
• 24 Quattrini C, Jeziorska M, Tavakoli M. et al . The Neuropad test: a visual indicator test for human diabetic neuropathy.  Diabetologia.. 2008 Jun;  51 ((6)) 1046-1050
• 25 Schnell O, Mueler M, Standl E. Early detection of changes in the feet of diabetic patients with indicator test Neuropad^®.  Diabetes, Metabolism, and the Heart. 2008;  17 ((3)) 203-210
• 26 hahani BT, Halperin JJ, Boulu P. et al . SympaJthetic skin response: a method of assessing unmyelinated axon dysfunction in peripheral neuropathies.  J Neurol Neurosurg Psychiatry. 1984;  47 536-42
• 27 Singer W, Spies JM, McArthur J. et al . Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies.  Neurology.. 2004 Feb 24;  62 ((4)) 612-618
• 28 Spallone V, Morganti R, Siampli M. et al . Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy.  Diabet Med.. 2009 Jul;  26 ((7)) 686-692
• 29 Tentolouris N, Achtsidis V, Marinou K. et al . Evaluation of the self-administered indicator plaster neuropad for the diagnosis of neuropathy in diabetes.  Diabetes Care.. 2008 Feb;  31 ((2)) 236-237 Epub 2007 Nov 19
• 30 Young MJ, Boulton AJM, McLeod AF. et al . A multicentre study of the prevalence of diabetic peripheral neuropathy in the UK hospital clinic population.  Diabetologia. 1993;  36 150-156
• 31 Zick R, Schaeper T, Deeters U. Early detection of peripheral diabetic neuropathy – measurement of perspiration in the diabetic foot.  Klinikarzt. 2003;  32 288-229

Correspondence